Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine

J Pharmacol Exp Ther. 1993 Apr;265(1):392-400.

Abstract

In isolated mitochondria, t-butylhydroperoxide (t-BuOOH) and other pro-oxidants cause a permeability transition characterized by increased permeability to small ions, swelling and loss of membrane potential. Cyclosporin A and trifluoperazine inhibit this permeability transition. Here, we investigated the role of the mitochondrial permeability transition in lethal cellular injury from t-BuOOH. Hepatocytes from fasted rats were isolated by collagenase perfusion, and cell viability was assessed by propidium iodide fluorescence. t-BuOOH caused dose- and time-dependent cell killing. Fructose, a substrate for glycolytic ATP formation, protected at lower (< or = 100 microM), but not at higher concentrations of t-BuOOH. In fructose-treated cells, oligomycin (10 micrograms/ml) delayed cell killing after 100 to 300 microM t-BuOOH, whereas cyclosporin A (0.5 microM) plus trifluoperazine (5 microM) even more potently reduced lethal injury. In hepatocyte suspensions, 100 microM t-BuOOH caused mitochondrial depolarization as determined by release of rhodamine 123. Cyclosporin A plus trifluoperazine in the presence of fructose substantially reduced release of rhodamine 123. Similarly, in single cultured hepatocytes viewed by laser scanning confocal microscopy, t-BuOOH caused leakage of rhodamine 123 from mitochondria, an event which preceded cell death and which was delayed by fructose in combination with cyclosporin A plus trifluoperazine. At 1 mM, t-BuOOH inhibited glycolysis, and fructose in combination with either oligomycin or cyclosporin A plus trifluoperazine had only a short-lived protective effect. In conclusion, t-BuOOH toxicity was progressive with increasing dosages. At low t-BuOOH (< or = 50 microM), mitochondrial ATP synthetic capacity was inhibited, but not uncoupled.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclosporine / pharmacology*
  • Fructose / pharmacology*
  • Glycolysis*
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / physiology
  • Lactates / biosynthesis
  • Lactic Acid
  • Liver / cytology
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Membrane Potentials / drug effects
  • Mitochondria, Liver / drug effects*
  • Mitochondria, Liver / metabolism
  • Oligomycins / pharmacology
  • Oxidative Phosphorylation
  • Peroxides / antagonists & inhibitors
  • Peroxides / toxicity*
  • Pyruvates / metabolism
  • Pyruvic Acid
  • Rats
  • Rats, Sprague-Dawley
  • Trifluoperazine / pharmacology*
  • tert-Butylhydroperoxide

Substances

  • Lactates
  • Oligomycins
  • Peroxides
  • Pyruvates
  • Trifluoperazine
  • Fructose
  • Lactic Acid
  • Cyclosporine
  • Pyruvic Acid
  • Adenosine Triphosphate
  • tert-Butylhydroperoxide